9 Meters Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CORECAP ADVISORS, LLC | 02/10/2023 | 101 | $127 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| STIFEL FINANCIAL CORP | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF MONTREAL /CAN/ | 02/01/2023 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| ROTHSCHILD INVESTMENT CORP /IL | 01/19/2023 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 02/08/2023 | 0 | $0 | -100.00% | 0.00% |
| KCM INVESTMENT ADVISORS LLC | 01/31/2023 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/21/2023 | 0 | $0 | -100.00% | 0.00% |
| WEDBUSH SECURITIES INC | 01/31/2023 | 0 | $0 | -100.00% | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| LAURION CAPITAL MANAGEMENT LP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 02/07/2023 | 0 | $0 | -100.00% | 0.00% |
| J.W. COLE ADVISORS, INC. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| CARNEGIE CAPITAL ASSET MANAGEMENT, LLC | 01/24/2023 | 0 | $0 | -100.00% | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
| GATEWAY ADVISORY, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| AXIOM INVESTMENT MANAGEMENT LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
| CUTLER GROUP LLC / CA | 02/07/2023 | 0 | $0 | -100.00% | 0.00% |
| PROSPERA FINANCIAL SERVICES INC | 02/08/2023 | 0 | $0 | -100.00% | 0.00% |
| ADVISER INVESTMENTS LLC | 01/19/2023 | 0 | $0 | -100.00% | 0.00% |
| PRIVATE ADVISOR GROUP, LLC | 01/18/2023 | 0 | $0 | -100.00% | 0.00% |
| ERGOTELES LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| MCF ADVISORS LLC | 01/31/2023 | 0 | $0 | -100.00% | 0.00% |
9 Meters Biopharma, Inc.institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of 9 Meters Biopharma, Inc.. The most heavily invested institutionals were:
Axiom Investment Management LLC: 0
Ashfield Capital Partners, LLC: 33,353
WIPFLI FINANCIAL ADVISORS LLC,: 4,500
REGENTATLANTIC CAPITAL LLC: 0
Frontier Wealth Management LLC: 30,000
Amalgamated Financial Corp.: 36,861
0.00% of 9 Meters Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 104,714 shares in the last 24 months. This purchase volume represents approximately $7,330 in transactions.